Healthy Transitions: Menopause Effect on Obesity, Energy Balance, and Insulin
Completed
Conditions studied: Menopause
In brief
The purpose of this study is to determine the effect of menopause on obesity, energy balance, and insulin in postmenopausal, obese women.
Key facts
- Study ID
- NCT00412269
- Run by
- Pennington Biomedical Research Center
- People needed
- 160
- Starts
- 1998-02-01
- Expected to finish
- 2007-03-01
- Last updated by the study team
- 2016-01-25
Who can join
Age: 47 and older, up to 52. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Age 47-52 yr, at time of enrollment
- Body Mass Index 25-40
- Normal oral glucose tolerance test by National Diabetes Data Group criteria
- Premenopausal, defined by FSH levels <30mIU/ml and at least 5 menstrual periods in the last 6 months
- Able to confirm ethnic heritage of past 2 generations in family
You may not qualify if…
- hypertension or hypercholesterolemia requiring medication
- regular use of medications that influence glucose tolerance
- use of oral contraceptives within the past 6 months
- history of myocardial infarction or significant coronary vascular disease or stroke
- history of endocrine, kidney, or liver disease or malignancy
- any psychopathology, including eating disorders, substance abuse, and major depression
- unable to complete longitudinal study commitment, including anticipating moving out of the area within the next 5 years.
Where it is running
- Pennington Biomedical Research Center — Baton Rouge, Louisiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.